Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

GeneDx Holdings (WGS) Accumulated Depreciation & Amortization (2020 - 2025)

Historic Accumulated Depreciation & Amortization for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $2.4 million.

  • GeneDx Holdings' Accumulated Depreciation & Amortization fell 90.83% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year decrease of 90.83%. This contributed to the annual value of $7.9 million for FY2024, which is 5989.85% down from last year.
  • Per GeneDx Holdings' latest filing, its Accumulated Depreciation & Amortization stood at $2.4 million for Q3 2025, which was down 90.83% from $2.3 million recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' Accumulated Depreciation & Amortization ranged from a high of $50.0 million in Q4 2022 and a low of $1.7 million during Q2 2024
  • Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $5.5 million (2021), whereas its average is $8.7 million.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first skyrocketed by 12928.42% in 2022, then plummeted by 7491.94% in 2024.
  • Over the past 5 years, GeneDx Holdings' Accumulated Depreciation & Amortization (Quarter) stood at $21.8 million in 2021, then skyrocketed by 129.28% to $50.0 million in 2022, then tumbled by 60.6% to $19.7 million in 2023, then tumbled by 59.9% to $7.9 million in 2024, then tumbled by 69.62% to $2.4 million in 2025.
  • Its last three reported values are $2.4 million in Q3 2025, $2.3 million for Q2 2025, and $2.2 million during Q1 2025.